Shanxi Zhendong Pharmaceutical Tangible Net Worth Ratio
Shanxi Zhendong Pharmaceutical tangible net worth ratio. Shanxi Zhendong Pharmaceutical (300158) has a Tangible Net Worth Ratio of 88.8% as of September 2025. This metric is calculated by deducting intangible assets (CN¥407.29 Million) from net assets (CN¥3.63 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check 300158 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Shanxi Zhendong Pharmaceutical (2007–2024)
Tangible net worth ratio of Shanxi Zhendong Pharmaceutical from 2007 to 2024. This chart shows how Shanxi Zhendong Pharmaceutical's Tangible Net Worth Ratio has changed across 18 annual periods from 2007 to 2024. As of September 2025, the ratio stands at 88.8%, reflecting net assets of CN¥3.63 Billion with intangible assets of CN¥407.29 Million CNY. See 300158 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Shanxi Zhendong Pharmaceutical Tangible Net Worth Ratio by Year (2007–2024)
Shanxi Zhendong Pharmaceutical tangible net worth ratio by year from 2007 to 2024. The table below presents the year-by-year Tangible Net Worth Ratio for Shanxi Zhendong Pharmaceutical from 2007 to 2024, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 300158 market cap overview.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 89.8% | CN¥3.66 Billion | CN¥371.90 Million | CN¥4.98 Billion | ▼ -1.3 pp |
| 2023 | 91.2% | CN¥5.14 Billion | CN¥454.50 Million | CN¥6.18 Billion | ▼ -0.2 pp |
| 2022 | 91.4% | CN¥5.22 Billion | CN¥451.18 Million | CN¥6.55 Billion | ▼ -3.2 pp |
| 2021 | 94.5% | CN¥8.05 Billion | CN¥439.60 Million | CN¥10.09 Billion | ▲ +1.0 pp |
| 2020 | 93.6% | CN¥5.63 Billion | CN¥362.53 Million | CN¥7.60 Billion | ▲ +1.0 pp |
| 2019 | 92.5% | CN¥5.44 Billion | CN¥405.86 Million | CN¥6.92 Billion | ▼ -0.1 pp |
| 2018 | 92.7% | CN¥5.36 Billion | CN¥392.70 Million | CN¥7.21 Billion | ▼ -0.4 pp |
| 2017 | 93.0% | CN¥5.56 Billion | CN¥386.74 Million | CN¥7.61 Billion | ▲ +0.1 pp |
| 2016 | 92.9% | CN¥5.27 Billion | CN¥371.80 Million | CN¥6.87 Billion | ▲ +9.5 pp |
| 2015 | 83.5% | CN¥2.03 Billion | CN¥335.78 Million | CN¥4.07 Billion | ▼ -1.1 pp |
| 2014 | 84.5% | CN¥1.97 Billion | CN¥304.79 Million | CN¥2.86 Billion | ▼ -0.5 pp |
| 2013 | 85.1% | CN¥1.96 Billion | CN¥292.42 Million | CN¥2.80 Billion | ▼ -2.1 pp |
| 2012 | 87.2% | CN¥1.90 Billion | CN¥243.21 Million | CN¥2.58 Billion | ▼ -5.0 pp |
| 2011 | 92.2% | CN¥1.86 Billion | CN¥145.04 Million | CN¥2.26 Billion | ▼ -6.0 pp |
| 2010 | 98.2% | CN¥1.78 Billion | CN¥32.16 Million | CN¥2.17 Billion | ▲ +6.9 pp |
| 2009 | 91.3% | CN¥359.31 Million | CN¥31.43 Million | CN¥643.18 Million | ▲ +1.0 pp |
| 2008 | 90.2% | CN¥266.72 Million | CN¥26.02 Million | CN¥496.69 Million | ▲ +2.6 pp |
| 2007 | 87.7% | CN¥176.42 Million | CN¥21.79 Million | CN¥466.70 Million | — |